Technical Analysis for ABT - Abbott Laboratories

Grade Last Price % Change Price Change
grade B 48.74 -1.12% -0.55
ABT closed down 1.12 percent on Friday, August 18, 2017, on 82 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Flat Flat
See historical ABT trend table...

Date Alert Name Type % Chg
Aug 18 Fell Below 50 DMA Bearish 0.00%
Aug 16 180 Bullish Setup Bullish Swing Setup -2.15%
Aug 14 Stochastic Buy Signal Bullish -0.69%
Aug 11 Crossed Above 50 DMA Bullish 0.41%
Aug 11 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.41%

Older signals for ABT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, pain, fever, inflammation, hypothyroidism, gynecological disorders, intrahepatic cholestasis or depressive symptoms, physiological rhythm of the colon, dyslipidemia, and hypertension, as well as provides anti-infective and influenza vaccines. The company's Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; genomic-based tests; hematology systems and reagents; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products comprising various forms of prepared infant and follow-on formula. The company's Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular disease. Abbott Laboratories also offers blood glucose monitoring meters, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Is ABT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 51.13
52 Week Low 36.9402
Average Volume 5,881,161
200-Day Moving Average 43.5904
50-Day Moving Average 48.7886
20-Day Moving Average 49.351
10-Day Moving Average 48.929
Average True Range 0.6265
ADX 18.44
+DI 24.4
-DI: 23.95
Chandelier Exit (Long, 3 ATRs) 49.2505
Chandelier Exit (Short, 3 ATRs) 49.9295
Upper Bollinger Band 50.7644
Lower Bollinger Band 47.9376
Percent B (%b) 0.28
Bandwidth 0.057279
MACD Line 0.066
MACD Signal Line 0.1495
MACD Histogram -0.0836